Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?
Mansur, Rodrigo B
Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists? [electronic resource] - Neuropharmacology 07 2018 - 335-342 p. digital
Publication Type: Journal Article; Review
1873-7064
10.1016/j.neuropharm.2018.01.048 doi
Animals
Cognitive Dysfunction--epidemiology
Comorbidity
Glucagon-Like Peptide-1 Receptor--metabolism
Humans
Metabolic Diseases--epidemiology
Mood Disorders--epidemiology
Glucagon-Like Peptide-1 Receptor Agonists
Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists? [electronic resource] - Neuropharmacology 07 2018 - 335-342 p. digital
Publication Type: Journal Article; Review
1873-7064
10.1016/j.neuropharm.2018.01.048 doi
Animals
Cognitive Dysfunction--epidemiology
Comorbidity
Glucagon-Like Peptide-1 Receptor--metabolism
Humans
Metabolic Diseases--epidemiology
Mood Disorders--epidemiology
Glucagon-Like Peptide-1 Receptor Agonists